Intellia Therapeutics, Inc. - Common Stock (NTLA)
CUSIP: 45826J105
Q2 2016 13F Holders as of 30 Jun 2016
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 116,932,531
- Total 13F shares
- 14,055,535
- Share change
- +13,976,857
- Total reported value
- $300,085,720
- Price per share
- $21.35
- Number of holders
- 61
- Value change
- +$298,405,720
- Number of buys
- 59
- Number of sells
- 1
Quarterly Holders Quick Answers
What is CUSIP 45826J105?
CUSIP 45826J105 identifies NTLA - Intellia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45826J105:
Top shareholders of NTLA - Intellia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| IFP Advisors, Inc |
13F
|
Company |
0%
|
215
|
$4,000 | — | 31 Mar 2016 |
Institutional Holders of Intellia Therapeutics, Inc. - Common Stock (NTLA) as of Q2 2016
As of 30 Jun 2016,
Intellia Therapeutics, Inc. - Common Stock (NTLA) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,055,535 shares.
The largest 10 holders included
FMR LLC, ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, Temasek Holdings (Private) Ltd, Foresite Capital Management III, LLC, BlackRock Advisors LLC, VANGUARD GROUP INC, EcoR1 Capital, LLC, MORGAN STANLEY, and FRANKLIN RESOURCES INC.
This page lists
61
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2016 vs Q1 2016 Across Filers
Q1 2016 holders
1
Q2 2016 holders
61
Holder diff
60
| Investor | Q1 2016 Shares | Q2 2016 Shares | Share Diff | Share Chg % | Q1 2016 Value $ | Q2 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.